COVID-19—Importance for Patients on the Waiting List and after Kidney Transplantation—A Single Center Evaluation in 2020–2021
(1) Background: Dialysis patients and recipients of a kidney allograft are at high risk for infection with SARS-CoV-2. It has been shown that the development of potent neutralizing humoral immunity against SARS CoV-2 leads to an increased probability of survival. However, the question of whether imm...
Main Authors: | Simone C. Boedecker, Pascal Klimpke, Daniel Kraus, Stefan Runkel, Peter R. Galle, Martina Koch, Julia Weinmann-Menke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/4/429 |
Similar Items
-
Reasons referred by individuals who were not on kidney transplantation waiting lists
by: Juliana Dall’Agnol, et al.
Published: (2022-12-01) -
THE EXPERIENCE OF WAITING LIST MANAGEMENT FOR LIVER TRANSPLANTATION IN EKATERINBURG
by: E. N. Bessonova, et al.
Published: (2011-12-01) -
Management of variceal bleeding in the liver transplant waiting list
by: V. L. Korobka, et al.
Published: (2021-01-01) -
Cholelithiasis in patients on the kidney transplant waiting list
by: André Thiago Scandiuzzi Brito, et al.
Published: (2010-01-01) -
MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome
by: Gerd R. Silberhumer, et al.
Published: (2023-05-01)